| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.58e-06 | 3 | 15 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.77e-05 | 14 | 15 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 8.00e-05 | 18 | 15 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.42e-04 | 31 | 15 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.74e-04 | 33 | 15 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.60e-03 | 102 | 15 | 2 | GO:0043178 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.12e-03 | 129 | 15 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.83e-03 | 140 | 15 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.59e-03 | 151 | 15 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 7.20e-03 | 172 | 15 | 2 | GO:0044325 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 8.98e-03 | 193 | 15 | 2 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 9.34e-03 | 197 | 15 | 2 | GO:0022834 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.73e-05 | 9 | 15 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.63e-05 | 11 | 15 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.78e-03 | 88 | 15 | 2 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.96e-03 | 114 | 15 | 2 | GO:0016528 | |
| HumanPheno | Nasogastric tube feeding in infancy | 1.21e-05 | 37 | 7 | 3 | HP:0011470 | |
| Domain | InsP3_rcpt-bd | 1.56e-06 | 3 | 14 | 2 | IPR000493 | |
| Domain | RIH_assoc | 7.81e-06 | 6 | 14 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 7.81e-06 | 6 | 14 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.81e-06 | 6 | 14 | 2 | PF08709 | |
| Domain | RYDR_ITPR | 7.81e-06 | 6 | 14 | 2 | PF01365 | |
| Domain | RIH_dom | 7.81e-06 | 6 | 14 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.81e-06 | 6 | 14 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.81e-06 | 6 | 14 | 2 | IPR015925 | |
| Domain | - | 7.81e-06 | 6 | 14 | 2 | 1.25.10.30 | |
| Domain | MIR | 2.34e-05 | 10 | 14 | 2 | PS50919 | |
| Domain | MIR | 2.34e-05 | 10 | 14 | 2 | PF02815 | |
| Domain | MIR | 2.34e-05 | 10 | 14 | 2 | SM00472 | |
| Domain | MIR_motif | 2.34e-05 | 10 | 14 | 2 | IPR016093 | |
| Domain | ARM-type_fold | 1.86e-03 | 339 | 14 | 3 | IPR016024 | |
| Domain | Ion_trans_dom | 3.20e-03 | 114 | 14 | 2 | IPR005821 | |
| Domain | Ion_trans | 3.20e-03 | 114 | 14 | 2 | PF00520 | |
| Domain | - | 1.29e-02 | 679 | 14 | 3 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.36e-02 | 693 | 14 | 3 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.37e-02 | 694 | 14 | 3 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.84e-02 | 775 | 14 | 3 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.85e-02 | 777 | 14 | 3 | PS00028 | |
| Domain | Znf_C2H2-like | 1.97e-02 | 796 | 14 | 3 | IPR015880 | |
| Domain | Znf_C2H2 | 2.03e-02 | 805 | 14 | 3 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.05e-02 | 808 | 14 | 3 | SM00355 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 4.52e-06 | 5 | 10 | 2 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 6.78e-06 | 6 | 10 | 2 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.63e-05 | 9 | 10 | 2 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.03e-05 | 10 | 10 | 2 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.48e-05 | 11 | 10 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.48e-05 | 11 | 10 | 2 | M27466 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 3.52e-05 | 13 | 10 | 2 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.52e-05 | 13 | 10 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.52e-05 | 13 | 10 | 2 | M47696 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.52e-05 | 13 | 10 | 2 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 5.41e-05 | 16 | 10 | 2 | M26945 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.70e-05 | 19 | 10 | 2 | M47760 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 7.70e-05 | 19 | 10 | 2 | M27423 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.70e-05 | 19 | 10 | 2 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 8.55e-05 | 20 | 10 | 2 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 9.44e-05 | 21 | 10 | 2 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.04e-04 | 22 | 10 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.04e-04 | 22 | 10 | 2 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.14e-04 | 23 | 10 | 2 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.35e-04 | 25 | 10 | 2 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.57e-04 | 27 | 10 | 2 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.57e-04 | 27 | 10 | 2 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.70e-04 | 28 | 10 | 2 | M924 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.22e-04 | 32 | 10 | 2 | MM14983 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 2.82e-04 | 36 | 10 | 2 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 2.82e-04 | 36 | 10 | 2 | M39831 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.66e-04 | 41 | 10 | 2 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 3.84e-04 | 42 | 10 | 2 | M791 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 4.22e-04 | 44 | 10 | 2 | M39845 | |
| Pathway | SIG_CHEMOTAXIS | 4.41e-04 | 45 | 10 | 2 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 4.61e-04 | 46 | 10 | 2 | M8626 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 5.45e-04 | 50 | 10 | 2 | M47951 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 6.12e-04 | 53 | 10 | 2 | MM15716 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.35e-04 | 54 | 10 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.35e-04 | 54 | 10 | 2 | M27460 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 6.35e-04 | 54 | 10 | 2 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 6.59e-04 | 55 | 10 | 2 | M47952 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 8.11e-04 | 61 | 10 | 2 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 8.37e-04 | 62 | 10 | 2 | M27321 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.07e-03 | 70 | 10 | 2 | M3115 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.07e-03 | 70 | 10 | 2 | M8232 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.13e-03 | 72 | 10 | 2 | MM14631 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.19e-03 | 74 | 10 | 2 | M48080 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.19e-03 | 74 | 10 | 2 | MM15962 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.26e-03 | 76 | 10 | 2 | M9052 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.26e-03 | 76 | 10 | 2 | MM15051 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.32e-03 | 78 | 10 | 2 | M1921 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.46e-03 | 82 | 10 | 2 | M27110 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.60e-03 | 86 | 10 | 2 | M916 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.60e-03 | 86 | 10 | 2 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.60e-03 | 86 | 10 | 2 | M27206 | |
| Pathway | KEGG_GAP_JUNCTION | 1.75e-03 | 90 | 10 | 2 | M4013 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.75e-03 | 90 | 10 | 2 | M6467 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.95e-03 | 95 | 10 | 2 | M29842 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 2.16e-03 | 100 | 10 | 2 | M27467 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.20e-03 | 101 | 10 | 2 | M1979 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.29e-03 | 103 | 10 | 2 | MM15196 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.42e-03 | 106 | 10 | 2 | M27077 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.51e-03 | 108 | 10 | 2 | M17034 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 2.75e-03 | 113 | 10 | 2 | M16817 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.84e-03 | 115 | 10 | 2 | M9387 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.62e-03 | 130 | 10 | 2 | M27454 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 3.67e-03 | 131 | 10 | 2 | MM15717 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 3.84e-03 | 134 | 10 | 2 | M29840 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.18e-03 | 140 | 10 | 2 | M27484 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.36e-03 | 143 | 10 | 2 | M27107 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.54e-03 | 146 | 10 | 2 | M27288 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.60e-03 | 147 | 10 | 2 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.85e-03 | 151 | 10 | 2 | M39329 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 5.04e-03 | 154 | 10 | 2 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 5.17e-03 | 156 | 10 | 2 | M39475 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.76e-03 | 165 | 10 | 2 | MM15026 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 5.83e-03 | 166 | 10 | 2 | M16024 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 5.83e-03 | 166 | 10 | 2 | M608 | |
| Pathway | REACTOME_HEMOSTASIS | 6.41e-03 | 571 | 10 | 3 | MM14472 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.67e-03 | 178 | 10 | 2 | M2890 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 7.27e-03 | 186 | 10 | 2 | M27175 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.61e-03 | 203 | 10 | 2 | M5485 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.19e-03 | 210 | 10 | 2 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.78e-03 | 217 | 10 | 2 | M18437 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 9.96e-03 | 219 | 10 | 2 | M29836 | |
| Pathway | REACTOME_HEMOSTASIS | 1.04e-02 | 679 | 10 | 3 | M8395 | |
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 1.98e-07 | 2 | 16 | 2 | 19120126 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 18708078 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 15201137 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 1.98e-07 | 2 | 16 | 2 | 23582047 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 31979185 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 17890015 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 10874040 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 18547250 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 9808793 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 5.95e-07 | 3 | 16 | 2 | 24904548 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 36350267 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 32320395 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 5.95e-07 | 3 | 16 | 2 | 27777977 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 11413485 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 5.95e-07 | 3 | 16 | 2 | 23983250 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 20395455 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 17327232 | ||
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 5.95e-07 | 3 | 16 | 2 | 9858485 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 5.95e-07 | 3 | 16 | 2 | 17581770 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 17437169 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 23223241 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 20427533 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 5.95e-07 | 3 | 16 | 2 | 18241669 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 16014380 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 18194433 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 5.95e-07 | 3 | 16 | 2 | 1693919 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 19068129 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 23955339 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 25215520 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 28419336 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 21818117 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 19120137 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 11163362 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 1.19e-06 | 4 | 16 | 2 | 21424589 | |
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 1.19e-06 | 4 | 16 | 2 | 35494252 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 28615414 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 10828023 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 1.98e-06 | 5 | 16 | 2 | 21568942 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 11782428 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.97e-06 | 6 | 16 | 2 | 16844763 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 23463619 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 20519450 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 2.97e-06 | 6 | 16 | 2 | 21762810 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.97e-06 | 6 | 16 | 2 | 25966694 | |
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 4.16e-06 | 7 | 16 | 2 | 22495310 | |
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 11860456 | ||
| Pubmed | 7.13e-06 | 9 | 16 | 2 | 25737585 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 1.09e-05 | 11 | 16 | 2 | 27514653 | |
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 20824138 | ||
| Pubmed | 1.80e-05 | 14 | 16 | 2 | 34630045 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 2.08e-05 | 15 | 16 | 2 | 28578927 | |
| Pubmed | 4.56e-05 | 22 | 16 | 2 | 11696558 | ||
| Pubmed | 5.44e-05 | 24 | 16 | 2 | 10843712 | ||
| Pubmed | 8.00e-05 | 29 | 16 | 2 | 32123907 | ||
| Pubmed | 8.33e-05 | 529 | 16 | 4 | 14621295 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.38e-04 | 38 | 16 | 2 | 30786075 | |
| Interaction | BANK1 interactions | 3.40e-05 | 12 | 15 | 2 | int:BANK1 | |
| Interaction | IRAG1 interactions | 4.68e-05 | 14 | 15 | 2 | int:IRAG1 | |
| Interaction | TESPA1 interactions | 6.17e-05 | 16 | 15 | 2 | int:TESPA1 | |
| Interaction | TRPC4 interactions | 1.30e-04 | 23 | 15 | 2 | int:TRPC4 | |
| Interaction | RASEF interactions | 1.54e-04 | 25 | 15 | 2 | int:RASEF | |
| Interaction | TRPC1 interactions | 2.08e-04 | 29 | 15 | 2 | int:TRPC1 | |
| Interaction | BBOX1 interactions | 2.08e-04 | 29 | 15 | 2 | int:BBOX1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 5.08e-03 | 330 | 15 | 2 | chr22q13 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 8.26e-07 | 3 | 10 | 2 | 297 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.07e-03 | 718 | 10 | 3 | 28 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 175 | 16 | 3 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 3.23e-05 | 177 | 16 | 3 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 3.23e-05 | 177 | 16 | 3 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-05 | 187 | 16 | 3 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 6.89e-06 | 197 | 15 | 4 | 3836_UP | |
| Drug | xestospongin C | 2.66e-05 | 12 | 15 | 2 | ctd:C511704 | |
| Disease | Brain Hypoxia | 2.41e-07 | 2 | 15 | 2 | C1527348 | |
| Disease | Anoxia of brain | 2.41e-07 | 2 | 15 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 2.41e-07 | 2 | 15 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 2.41e-07 | 2 | 15 | 2 | C0003132 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.59e-05 | 12 | 15 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | basophil measurement | 4.20e-04 | 60 | 15 | 2 | EFO_0803539 | |
| Disease | diffuse plaque measurement | 4.70e-04 | 758 | 15 | 4 | EFO_0010699 | |
| Disease | Microcephaly | 5.23e-04 | 67 | 15 | 2 | C0025958 | |
| Disease | Neurodevelopmental Disorders | 1.00e-03 | 93 | 15 | 2 | C1535926 | |
| Disease | obesity (implicated_via_orthology) | 5.21e-03 | 215 | 15 | 2 | DOID:9970 (implicated_via_orthology) | |
| Disease | eosinophil percentage of leukocytes | 5.84e-03 | 746 | 15 | 3 | EFO_0007991 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYACRQERHMIMHKR | 501 | P49711 | |
| LAFERRHEFMALCMR | 221 | Q9NPC4 | |
| RHEFMALCMRDFVDH | 226 | Q9NPC4 | |
| RHFMFRNHLCLVFEM | 226 | Q13627 | |
| NLERCFHRAMMKHFP | 526 | Q9BXF3 | |
| ASFCRLMLHMHVDRD | 776 | Q14571 | |
| ICRKMLHRHMLIFRL | 1331 | Q6ZRR7 | |
| LRMVEHCLHMFDRMV | 96 | Q8IY49 | |
| YDLRASFCRLMLHMH | 776 | Q14643 | |
| LVRDKMMECHFRFRH | 321 | O75648 | |
| MMECHFRFRHQMALV | 326 | O75648 | |
| DMQRIHLRFMFRHRS | 501 | Q92608 | |
| HTRMRMFMHLRQDLE | 466 | Q92613 | |
| FETDMERRCKMHKRR | 436 | Q96EK5 | |
| MYCDKMFHRKDHLRN | 101 | Q9UPG8 | |
| CRYMADVIRHMRLHT | 236 | Q96NL3 | |
| FVKCADMKDRRMHHG | 501 | Q2WGJ6 |